Liraglutide
Products: Victoza · Saxenda
Overview
Liraglutide is the active ingredient. Victoza is approved for type 2 diabetes; Saxenda for chronic weight management.
How It Works
It activates GLP-1 receptors with once-daily dosing.
Approved Uses
Product-specific; check each label.
Clinical Evidence
The SCALE and LEADER trials studied weight and cardiovascular outcomes.
Common Side Effects
Nausea, diarrhea, constipation and headache.
Important Warnings
Boxed warning regarding thyroid C-cell tumors.
Questions to Ask Your Healthcare Provider
- Is a GLP-1 medication appropriate for my health history?
- Which product and indication applies to me?
- What side effects should I watch for?
- How should I adjust nutrition and exercise?
- What happens if I stop the medication?
References
FDA product labeling and published trial reports. Full citations will be listed here.
Educational only. GLP-1 Academy does not make personalized prescribing recommendations.